Fujimura Taku相关文献与解析，生知库 | 链接生命科学的每一步

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)

纳武利尤单抗治疗不可切除的皮肤上皮恶性肿瘤：一项开放标签、单臂、多中心 II 期试验 (NMSC-PD1)

Nakamura, Yoshio; Yamazaki, Naoya; Namikawa, Kenjiro; Uchi, Hiroshi; Mori, Shoichiro; Ogawa-Momohara, Mariko; Fujimura, Taku; Takenouchi, Tatsuya; Kurimoto, Mana; Yamamoto, Yuki; Otsuka, Atsushi; Kabashima, Kenji; Fusumae, Takayuki; Hirai, Ikuko; Tanese, Keiji; Saito, Yasuko; Amagai, Masayuki; Takemura, Ryo; Sato, Yasunori; Funakoshi, Takeru

肿瘤

Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies

综合基因组分析在175例对标准疗法无效的日本晚期皮肤恶性肿瘤患者中的临床应用价值

期刊:

影响因子:

doi:10.1016/j.jdin.2026.01.012

Kambayashi, Yumi; Fujimura, Taku; Kato, Hiroshi; Kado, Soichiro; Maekawa, Takeo; Ono, Fumitaka; Ito, Takamichi; Aoki, Megumi; Matsushita, Shigeto; Miyashita, Azusa; Fukushima, Satoshi; Rokunohe, Daiki; Yamazaki, Emi; Takahashi-Watanabe, Manami; Asano, Masayuki; Asano, Yoshihide

Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition

皮肤恶性肿瘤中的纤溶酶原激活物抑制剂-1：抑制该抑制剂的治疗意义

期刊:Biomolecules

影响因子:4.8

doi:10.3390/biom15091317

Fujimura, Taku; Muto, Yusuke; Asano, Yoshihide

PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic Resistance

PAI-1在皮肤恶性肿瘤中的作用：肿瘤进展和治疗耐药性的关键调控因子

期刊:Current Treatment Options in Oncology

影响因子:4.7

doi:10.1007/s11864-025-01357-x

Fujimura, Taku; Asano, Yoshihide

Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review

黑色素瘤免疫疗法的最新进展：新型疗法研发展望：简要综述

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17132265

Muto, Yusuke; Fujimura, Taku; Asano, Yoshihide

Impact of Hyaluronic Acid on the Cutaneous T-Cell Lymphoma Microenvironment: A Novel Anti-Tumor Mechanism of Bexarotene

透明质酸对皮肤T细胞淋巴瘤微环境的影响：贝沙罗汀的新型抗肿瘤机制

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17020324

Ikawa, Tetsuya; Yamazaki, Emi; Amagai, Ryo; Kambayashi, Yumi; Sekine, Mana; Takahashi, Takuya; Asano, Yoshihide; Fujimura, Taku

An Evaluation of Prognostic Factors in Cutaneous Squamous Cell Carcinoma: A Single-Center Study of 237 Japanese Cases.

皮肤鳞状细胞癌预后因素评价：一项针对 237 例日本病例的单中心研究

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm14041243

Yamazaki Emi, Fujimura Taku, Takahashi-Watanabe Manami, Amagai Ryo, Tamabuchi Erika, Oka Kenta, Kambayashi Yumi, Hashimoto Akira, Omori Ryoko, Takahashi Takehiro, Asano Yoshihide

Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study

基于7442名日本患者的黑色素瘤皮肤癌统计数据：日本黑色素瘤研究

期刊:International Journal of Clinical Oncology

影响因子:2.8

doi:10.1007/s10147-025-02747-9

Fujisawa, Yasuhiro; Yoshikawa, Shusuke; Takenouchi, Tatsuya; Mori, Shoichiro; Asai, Jun; Uhara, Hisashi; Ichigosaki, Yuki; Fujimura, Taku; Nakamura, Yoshiyuki; Nakamura, Yasuhiro; Ohno, Fumitaka; Fukumoto, Takeshi; Ozawa, Toshiyuki; Namikawa, Kenjiro; Sugihara, Satoru; Hoashi, Toshihiko; Shimauchi, Takatoshi; Sawada, Yu; Iwata, Hiroaki; Maeda, Taku; Miyagawa, Takuya; Shibayama, Yoshitsugu; Hatta, Naohito; Kishi, Akiko; Ishikawa, Masashi; Kawahira, Hisao; Katoh, Norito; Okuyama, Ryuhei

Correction to: Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study

更正：基于7442名日本患者的黑色素瘤皮肤癌统计数据：日本黑色素瘤研究

期刊:International Journal of Clinical Oncology

影响因子:2.8

doi:10.1007/s10147-025-02814-1

Significance of PAI-1 on the development of skin cancer: Optimal targets for cancer therapies

PAI-1在皮肤癌发展中的意义：癌症治疗的最佳靶点

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)

纳武利尤单抗治疗不可切除的皮肤上皮恶性肿瘤：一项开放标签、单臂、多中心 II 期试验 (NMSC-PD1)

Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies

综合基因组分析在175例对标准疗法无效的日本晚期皮肤恶性肿瘤患者中的临床应用价值

Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition

皮肤恶性肿瘤中的纤溶酶原激活物抑制剂-1：抑制该抑制剂的治疗意义

PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic Resistance

PAI-1在皮肤恶性肿瘤中的作用：肿瘤进展和治疗耐药性的关键调控因子

Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review

黑色素瘤免疫疗法的最新进展：新型疗法研发展望：简要综述

Impact of Hyaluronic Acid on the Cutaneous T-Cell Lymphoma Microenvironment: A Novel Anti-Tumor Mechanism of Bexarotene

透明质酸对皮肤T细胞淋巴瘤微环境的影响：贝沙罗汀的新型抗肿瘤机制

An Evaluation of Prognostic Factors in Cutaneous Squamous Cell Carcinoma: A Single-Center Study of 237 Japanese Cases.

皮肤鳞状细胞癌预后因素评价：一项针对 237 例日本病例的单中心研究

Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study

基于7442名日本患者的黑色素瘤皮肤癌统计数据：日本黑色素瘤研究

Correction to: Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study

更正：基于7442名日本患者的黑色素瘤皮肤癌统计数据：日本黑色素瘤研究